Close Banner
Section Free  - Video Lectures

11. Using E-Cigarettes: What Clinicians Must Know

Published on June 1, 2020 Expired on April 1, 2025

Joji Suzuki, M.D.

Assistant Professor of Psychiatry - Harvard Medical School

Key Points

  • E-cigarettes may be safer than cigarettes but are not risk free.
  • Clinicians and patients must be aware of the emergence of vaping-related lung disease.
  • E-cigarettes may be a viable smoking cessation strategy compared with NRT.

Free Downloads for Offline Access

  • Free Download Audio File (MP3)
  • Free Download Video (MP4)
  • Free Download Presentation File (PPTX)

Slides and Transcript

Slide 1 of 8

So now, let's talk about E-Cigarettes: Are E-Cigarettes Justified?

Slide 2 of 8

So the e-cigarettes really emerged within the last decade or so. It has evolved very dramatically and changed quite a bit. The first-generation e-cigarettes were very simple, limited functionality, inefficient nicotine delivery with very short charge time but single voltage. But then there are second-generation e-cigs that had larger batteries, refillable cartridges, more efficient nicotine delivery, longer charge time but adjustable voltage. And then finally, we are at a stage of the third-generation e-cigarettes which are very advanced personal vaporizers and the nicotine delivery matches that of conventional cigarettes and these are very customizable, adjustable and refillable devices and have really become quite popular.
References:
  • Wagener, T. L., Floyd, E. L., Stepanov, I., Driskill, L. M., Frank, S. G., Meier, E., … & Queimado, L. (2017). Have combustible cigarettes met their match? The nicotine delivery profiles and harmful constituent exposures of second-generation and third-generation electronic cigarette users. Tobacco control, 26(e1), e23-e28.
Free Files
Success!
Check your inbox, we sent you all the materials there.

Slide 3 of 8

Now, from the perspective of smoking cessation, e-cigarettes do provide some advantages. It is considered an acceptable substitute to smoking tobacco cigarettes. And the director of the Office on Smoking and Health for the CDC in the United States stated that there's enough evidence to say that switching to electronic cigarettes from tobacco, you know, smoked cigarettes would likely be healthier and that there is some evidence that suggests that it can help in cessation.
References:
  • Wagener, T. L., Floyd, E. L., Stepanov, I., Driskill, L. M., Frank, S. G., Meier, E., … & Queimado, L. (2017). Have combustible cigarettes met their match? The nicotine delivery profiles and harmful constituent exposures of second-generation and third-generation electronic cigarette users. Tobacco control, 26(e1), e23-e28

Slide 4 of 8

The best randomized trial published to date came out in the New England Journal of Medicine in 2019. It was a randomized controlled trial of almost 1000 smokers in the UK and they were given either e-cigarettes or a nicotine replacement therapy with the outcome being one year of abstinence with biochemical validation. And those who were randomized to the e-cigarette group had twice the one-year abstinence rate than the nicotine replacement. So about 20% success rate in the e-cigarette group and about 10% in the NRT group. And no difference in the incidence of wheezing or other respiratory problems or other ailments associated with e-cigarettes at all.
References:
  • Hajek, P., Phillips-Waller, A., Przulj, D., Pesola, F., Myers Smith, K., Bisal, N., … & Ross, L. (2019). A randomized trial of e-cigarettes versus nicotine-replacement therapy. New England Journal of Medicine, 380(7), 629-637.
Free Files
Success!
Check your inbox, we sent you all the materials there.

Slide 5 of 8

Now that said, there are some concerns and disadvantages with e-cigarettes. Now, there are lots of people who do utilize e-cigarettes but it does not help them to quit. And in fact, this can create a problem where they become dual users, meaning these individuals will keep continuing to smoke their tobacco and utilize e-cigarettes when they're not able to smoke their tobacco. So the net effect is actually increased nicotine exposure without any reduction in tobacco exposure which actually probably may be worse. And these devices can also be modified to deliver other types of substances like THC, for example, or psychedelics or other drugs of misuse. And these devices may be utilized by youth and that's probably the biggest concern that we have at this point, is that the prevalence of vaping, e-cigarette use among the youth has skyrocketed in the last five to 10 years. And in fact, e-cigarette is the most commonly utilized tobacco product or nicotine product among the youth today.
References:
  • Caponnetto, P., Saitta, D., Sweanor, D., & Polosa, R. (2015). What to consider when regulating electronic cigarettes: pros, cons and unintended consequences. International Journal of Drug Policy, 26(6), 554-559.

Slide 6 of 8

And now in addition to that, there had been increasing reports of vaping-related lung injuries. Now, these are typically in the context of whether it's illicitly produced vaping products particularly those containing THC but at this point, it's unclear exactly what's causing it. But individuals with this illness report using e-cigarettes by vaping or dabbing with imaging studies showing lung injury with the absence of any evidence for infectious causes that lead to these injuries and then the absence of any alternative possible diagnoses. And the current recommendation by the CDC is to avoid utilizing these products completely. Some states have resorted to banning flavoring agents that are utilized in these products which is thought to be the culprit for the vaping-related injury. So the recommendation for now is for people to avoid it if necessary and certainly the flavoring agents that are added should be avoided at all costs. And so it may be a helpful device to stop smoking or reduce smoking but in adolescents and youth, the data very strongly suggest that if individuals initiate vaping with e-cigarettes, they have a higher likelihood of picking up tobacco smoking later in life. So this is completely going in the opposite direction of the success that we've had with reducing tobacco smoking in the United States but the introduction of vaping may actually begin to reverse that. Now, the data from CDC suggest that currently 12th graders in the United States, probably over a third of them endorse having vaped within the past year. And for among 8th graders, it might be as much as one in five may have tried vaping in the past year. So this is an emerging problem and a serious concern.
References:
  • Perrine, C. G., Pickens, C. M., Boehmer, T. K., King, B. A., Jones, C. M., DeSisto, C. L., … & Landen, M. G. (2019). Characteristics of a multistate outbreak of lung injury associated with e-cigarette use, or vaping—United States, 2019. Morbidity and Mortality Weekly Report, 68(39), 860.
  • Caponnetto, P., Saitta, D., Sweanor, D., & Polosa, R. (2015). What to consider when regulating electronic cigarettes: pros, cons and unintended consequences. International Journal of Drug Policy, 26(6), 554-559.
Free Files
Success!
Check your inbox, we sent you all the materials there.

Slide 7 of 8

So key points. E-cigarettes from a legitimate manufacturer may be safer than cigarette smoking but they are not risk free. And clinicians and patients need to be educated by the emergence of vaping-related lung disease. And e-cigarettes may be a viable smoking cessation strategy compared to NRT. 

Slide 8 of 8

Free Files
Success!
Check your inbox, we sent you all the materials there.

Learning Objectives:

After completing this activity, the learner will be able to:

  1. Summarize the effects of nicotine in the body and recognize withdrawal symptoms.
  2. Learn strategies for speaking with patients about tobacco addiction and how to help them decide to quit.
  3. Identify available treatment options so as to prescribe the best choice for a given patient.

Original Release Date: 06/01/2020

Review and Re-release Date: 03/01/2024

Expiration Date: 04/01/2025

Expert: Joji Suzuki, M.D.

Medical Editor: Jessica Diaz, M.D

Relevant Financial Disclosures:

None of the faculty, planners, and reviewers for this educational activity have relevant financial relationship(s) to disclose during the last 24 months with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Contact Information: For questions regarding the content or access to this activity, contact us at support@psychopharmacologyinstitute.com

Instructions for Participation and Credit:

Participants must complete the activity online during the valid credit period that is noted above.

Follow these steps to earn CME credit:

  1. View the required educational content provided on this course page.
  2. Complete the Post Activity Evaluation for providing the necessary feedback for continuing accreditation purposes and for the development of future activities. NOTE: Completing the Post Activity Evaluation after the quiz is required to receive the earned credit.
  3. Download your certificate.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

Medical Academy designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Free Files
Success!
Check your inbox, we sent you all the materials there.
Continue in the website
Instant access modal

Become a Bronze, Silver, Gold, Bronze extended, Silver extended or Gold extended Member.

2025–26 Psychopharmacology CME Program

Unlock up to 155 CME Credits, including 40 SA CME Credits.